Medisan (Sep 2017)
Application of Heberprot-P® in a patient with neuroinfectious diabetic foot
Abstract
The case report of a 51 years patient with type 2 diabetes mellitus for around 26 years is described, to whom neuroinfectious diabetic foot was diagnosed. Initially, he was admitted to the Angiology Service of "Saturnino Lora Torres" Teaching Clinical Surgical Provincial Hospital in Santiago de Cuba, where Heberprot-P® was indicated as part of the treatment, first 3 bulbs of 75 mg each and then 8 bulbs of 25 mg; the latter were applied in an ambulatory way in the polyclinic of his health area. After 11 weeks of beginning the therapy the total scaring of the lesion was achieved.